| Monday: Morning | Monday: Afternoon | Tuesday: Morning |
| Abbvie | Hollister | Ipsen |
Monday 21 July 2025, 07.15am - 08.15am
Breakfast served from 07.00am
Join key rehabilitation management experts for a panel discussion on the common challenges in Rehabilitation Medicine. Key topics include: Evolving models of care in managing spasticity, Cerebral Palsy transition and Cervical Dystonia management – diagnosis and treatment
Speakers
A/Professor Barry Rawicki is a consultant physician in rehabilitation medicine. He obtained his medical degree at the University of Melbourne in 1978, and his specialist qualifications in Rehabilitation Medicine in 1985. He was appointed Associate Professor in the Department of Medicine, Monash University in 1999. He retired as the Medical Director of Paediatric Rehabilitation for the Victorian Paediatric Rehabilitation Service at Monash Children’s Hospital in Melbourne in August 2024 after establishing the service in 2007. He was previously Medical Director of Adult Rehabilitation Services at Monash Health. He has extensive experience in adult and paediatric rehabilitation. He has extensive experience in pain management including procedural approaches.
Dr John J Estell is a Consultant Physician in Rehabilitation Medicine, with appointments at St George and Calvary Hospitals. Dr Estell is the Co-Director of Aged and Integrated Care Division at St George Hospital, Head of Aged Care and Rehabilitation Medicine at Calvary Hospital. Dr Estell is a Rehabilitation Physician with an extensive experience in Spasticity management, Stroke Rehabilitation, Trauma Rehabilitation and able-bodied and disabled sports medicine.
Dr Warren Jenings-Bell is a Consultant Physician in Rehabilitation Medicine and Fellow of the Australasian Faculty of Rehabilitation Medicine within the Royal Australasian College of Physicians. He has developed proficiency in ultrasound-guided botulinum toxin injections for spasticity and cervical dystonia. Prior to his medical degree Warren studied Biomedical Science at the University of Wollongong, majoring in Anatomy. Warren now operates a private spasticity and cervical dystonia treatment service on the Sunshine Coast in Queensland. He runs anatomy and ultrasound workshops in Australia and internationally.
Monday 21 July 2025, 05.45pm - 07.00pm
Drinks & canapès served from 06.30pm
Neurogenic bladder dysfunction presents significant challenges in clinical practice, impacting patient quality of life and kidney health. Understanding the differences in neurogenic bladder among patients with conditions such as tetraplegia, paraplegia, and multiple sclerosis is essential. Understanding the variations in bladder capacity, compliance, and detrusor activity versus sphincter will directly influence management strategies. The session will explore the value of urodynamic studies to guide bladder management which is critical in the context of evidence-based practice.
Additionally, we will review evidence-based medical and surgical management options for both neurogenic bladder and sexual function ensuring participants are well-equipped to implement effective treatment plans.
The session will also explore sexuality and sexual function in patients with neurological impairment, emphasizing the importance of a holistic approach to rehabilitation.
This session will ensure that healthcare providers are able to tailor treatments to individual patient needs.
Speakers:
Mr Giovanni Losco is an adult and paediatric urologist from Christchurch, New Zealand. He completed fellowship training in paediatric urology at Birmingham Children’s Hospital and gained extensive experience in reconstructive urology, female urology, pelvic organ prolapse, mesh complications, urethroplasty and urological care of spinal injuries while working at the London Spinal Cord Injury Centre, Royal National Orthopaedic Hospital and the Institute of Urology, University College Hospital, London. He runs private services in Christchurch and Queenstown.
Tuesday 22 July 2025, 07.15am - 08.15am
Breakfast served from 07.00am
Experts will delve into the treatment of adult lower limb spasticity using clostridium botulinum type A (abobotulinumtoxinA). Drawing learnings from the Abolish (2024) prospective, observational study and real-world case studies, they will share valuable findings and practical applications. The session will conclude with an engaging panel discussion, offering attendees the opportunity to ask questions and gain deeper insights.
Speakers:
Dr. Helen Redmond MBBS, FAFRM (RACP) is a rehabilitation medicine physician based in Sydney, Australia, with extensive experience injecting botulinum toxin for spasticity. She leads the Spasticity Management Service at Liverpool Hospital Brain Injury Service, Southwest Sydney.
A/Professor Arun Aggarwal (MBBS, FRACP, FAFRM (RACP), FAFPM (ANZCA), PhD) is a VMO Neurologist at Concord Hospital and Honorary VMO at the RPAH Pain Management Centre. He recently retired from his Rehabilitation Medicine position at RPAH and Balmain hospitals, after 30 years, but continues to work in the private system. He has held an academic appointment at The University of Sydney Central Medical School since 2010.
Dr Matthew Tuminello (MBBS, FAFRM (RACP)) is a Consultant Physician in Rehabilitation Medicine based in Melbourne, Australia. He specializes in improving the lives of individuals with complex orthopedic injuries, and disorders of the brain, spinal cord, and peripheral neurological system. Dr. Tuminello holds specialist positions at Epworth HealthCare, Caulfield Hospital, and Masada Private Hospital.
g.tec medical engineering GmbH has focused on developing and producing top-notch brain-computer-interface systems for 25 years. From non-invasive EEG to invasive ECoG research and clinical systems, from 8 channels to 1024 channels, from functional brain mapping to neurorehabilitation and BCI research etc., g.tec has been collaborating with top universities and hospitals to advance the BCI field. recoveriX is the BCI neurorehabilitation system produced by g.tec and clinically proven efficacious in regaining motor functions in stroke and multiple sclerosis patients at any stages. recoveriX also has a franchise business model, which has now worldwide franchise partners in Europe, Canada, South Africa and Asia.
Speaker: Christy Li has joined g.tec since 2021 and has been focusing on promoting its ground-breaking brain-computer-Interface and neurotechnology. recoveriX is CE, TGA certified medical device and proven efficacious in many publications. Christy currently focuses on collaborating with researchers, therapists, neurologists and distributors In Asia Pacific countries to deploy BCI and recoveriX neurorehabilitation applications.
